Medications

Eight-week bedaquiline-linezolid noninferior for TB

A strategy of eight weeks of bedaquiline-linezolid is noninferior to a standard regimen for tuberculosis, according to a study published online Feb. 20 in the New England Journal of Medicine to coincide with the annual Conference ...

Medications

When is remdesivir effective for COVID-19?

Remdesivir was one of the first medications approved for treatment of COVID-19. Clinical studies evaluated its effectiveness, but did not generate conclusive results. A new analysis of the study data shows that a specific ...

page 19 from 40